Albireo Pharma logo
Albireo Pharma ALBO
report update icon

Quarterly report 2022-Q3
added 05-23-2026

Albireo Pharma Total Non Current Liabilities | ALBO

Annual Total Non Current Liabilities Albireo Pharma

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
- 79.1 M 53 M 50 M 42 K 359 K 59 K 1.01 M 6.15 M 7.34 M 1.14 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
79.1 M 42 K 19.8 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Non Current Liabilities Price % 24h Market Cap Country
bluebird bio bluebird bio
BLUE
170 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
276 K - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
12.3 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
9.41 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
31.9 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
274 K - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
9.97 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
10.2 M - -13.39 % $ 1.45 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
4.9 M $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
244 K - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
29.2 B $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
2.06 M $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
218 M - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
2.42 M - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
12 M - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
807 K - - $ 58.1 M usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
24.8 M - -14.27 % $ 1.7 M singaporeSingapore
Adverum Biotechnologies Adverum Biotechnologies
ADVM
27.3 M - - $ 86.2 M usaUSA
BELLUS Health BELLUS Health
BLU
932 K - - $ 2.47 B canadaCanada
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
20 M - - $ 13.6 B usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
2.53 M - - $ 29.6 M usaUSA
GeoVax Labs GeoVax Labs
GOVX
170 K $ 1.83 -4.45 % $ 8.35 M usaUSA
Unity Biotechnology Unity Biotechnology
UBX
13.3 M - -33.41 % $ 3.37 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
106 M - - $ 10.1 M usaUSA
Tyme Technologies Tyme Technologies
TYME
546 K - 8.07 % $ 54 M usaUSA
Karuna Therapeutics Karuna Therapeutics
KRTX
13.8 M - - $ 12.2 B usaUSA
Revance Therapeutics Revance Therapeutics
RVNC
541 M - - $ 309 M usaUSA
Aptinyx Aptinyx
APTX
114 K - -39.0 % $ 4.57 M usaUSA
TRACON Pharmaceuticals TRACON Pharmaceuticals
TCON
3.59 M - -1.38 % $ 46.8 M usaUSA
Forward Pharma A/S Forward Pharma A/S
FWP
43 K - -0.75 % $ 18.7 M danmarkDanmark
Theratechnologies Theratechnologies
THTX
41.8 M - - $ 83.9 M canadaCanada
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
10.2 M - 3.16 % $ 1.9 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
170 M - -15.15 % $ 60.3 M britainBritain
TFF Pharmaceuticals TFF Pharmaceuticals
TFFP
1.13 M - -60.05 % $ 125 K usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
91 M - -55.98 % $ 2.15 M usaUSA
Sage Therapeutics Sage Therapeutics
SAGE
10.5 M - - $ 527 M usaUSA
Paratek Pharmaceuticals Paratek Pharmaceuticals
PRTK
255 M - - $ 121 M usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
40.7 M - - $ 521 M usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
38.9 M $ 34.99 3.77 % $ 147 M usaUSA
Seelos Therapeutics Seelos Therapeutics
SEEL
7.49 M - -47.76 % $ 6.27 M usaUSA
Завод ДИОД Завод ДИОД
DIOD
89.5 M - - - russiaRussia
Kiromic BioPharma Kiromic BioPharma
KRBP
228 K - 6.61 % $ 3.08 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
15.9 M - - $ 2.18 B usaUSA
Fusion Pharmaceuticals Fusion Pharmaceuticals
FUSN
4.31 M - - $ 1.41 B canadaCanada
Gritstone Oncology Gritstone Oncology
GRTS
30.5 M - 0.42 % $ 213 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
854 K - 17.91 % $ 11.1 M usaUSA